ECSP23031196A - Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma - Google Patents

Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma

Info

Publication number
ECSP23031196A
ECSP23031196A ECSENADI202331196A ECDI202331196A ECSP23031196A EC SP23031196 A ECSP23031196 A EC SP23031196A EC SENADI202331196 A ECSENADI202331196 A EC SENADI202331196A EC DI202331196 A ECDI202331196 A EC DI202331196A EC SP23031196 A ECSP23031196 A EC SP23031196A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical composition
vaginal administration
composition suitable
ovumes
relates
Prior art date
Application number
ECSENADI202331196A
Other languages
English (en)
Inventor
Albertos Alfonso Enrique Moguel
Ramos Marysol Mendoza
Original Assignee
Exeltis Pharma Mexico S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exeltis Pharma Mexico S A De C V filed Critical Exeltis Pharma Mexico S A De C V
Publication of ECSP23031196A publication Critical patent/ECSP23031196A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica adecuada para administración vaginal en forma de óvulos y a su fabricación. La presente invención también se refiere a dicha composición farmacéutica para utilizar en la prevención y/o tratamiento de enfermedades infecciosas del sistema reproductor femenino.
ECSENADI202331196A 2020-10-29 2023-04-28 Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma ECSP23031196A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2020011523A MX2020011523A (es) 2020-10-29 2020-10-29 Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.

Publications (1)

Publication Number Publication Date
ECSP23031196A true ECSP23031196A (es) 2023-06-30

Family

ID=78695745

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202331196A ECSP23031196A (es) 2020-10-29 2023-04-28 Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma

Country Status (4)

Country Link
CL (1) CL2023001196A1 (es)
EC (1) ECSP23031196A (es)
MX (1) MX2020011523A (es)
WO (1) WO2022091016A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
CN101584703B (zh) * 2008-05-21 2011-11-09 杨立新 一种用于治疗阴道炎的药物组合物及其制备方法
KR20130130403A (ko) * 2012-05-22 2013-12-02 울산대학교 산학협력단 복강경하 자궁적출술 후 통증 치료 또는 완화용 경피 투여 조성물
CN103520090B (zh) * 2013-10-11 2015-12-09 哈尔滨欧替药业有限公司 替硝唑阴道膨胀栓及其制备方法和检测方法

Also Published As

Publication number Publication date
MX2020011523A (es) 2022-05-02
WO2022091016A1 (en) 2022-05-05
CL2023001196A1 (es) 2023-10-20

Similar Documents

Publication Publication Date Title
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
MX2020009758A (es) Producto combinado de inhibidor de bcl-2 o inhibidor dual de bcl-2/bcl-xl e inhibidor de btk y uso de este en la prevencion y/o tratamiento de enfermedades.
BR112015024411A2 (pt) desaza-purinonas macrocíclicas para o tratamento de infeções virais
CU24065B1 (es) Forma de dosificación farmacéutica que comprende nifedipino y un antagonista de angiotensina ii
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
BR112017000285A2 (pt) métodos de tratamento da profilaxia viral e kits de profilaxia de pré-exposição
MX2020012616A (es) Agonistas del receptor tipo toll (tlr7).
CL2016000787A1 (es) Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih).
CR20210507A (es) Composición farmacéutica acuosa de anticuerpo anti-il17a y su uso
CO7111317A2 (es) Método para el tratamiento de enfermedades ginecológicas
ECSP23031196A (es) Composición farmacéutica adecuada para administración vaginal en forma de óvulos y uso de la misma
BR112022014772A2 (pt) Dispersão sólida amorfa, composição farmacêutica e processos para a preparação destas
ECSP22092205A (es) Composición farmacéutica acuosa de levilimab y su uso
TR201904382T4 (tr) Vajinit tedavisi.
CL2019002020A1 (es) Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer.
CL2018002705A1 (es) Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales
CO2022002493A2 (es) Nanoemulsion de ácido 18p-glicirretínico
CL2017001679A1 (es) Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces
CO2018010142A2 (es) Proceso de preparación de fórmulas solidas de mesalazina
BR112022010340A2 (pt) Composições farmacêuticas
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
MX2020004105A (es) Formulacion farmaceutica.
BR112019002125A2 (pt) composição de comprimidos de alta carga de fármacos para o tratamento do hiv